These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 7587998)
21. [Critical analysis of controlled pharmacologic studies in obsessive compulsive disorder]. Brochier T; Hantouche E Encephale; 1989; 15(3):325-33. PubMed ID: 8641159 [TBL] [Abstract][Full Text] [Related]
22. Lamotrigine augmentation of serotonin re-uptake inhibitors in obsessive-compulsive disorder. Kumar TC; Khanna S Aust N Z J Psychiatry; 2000 Jun; 34(3):527-8. PubMed ID: 10881981 [No Abstract] [Full Text] [Related]
23. Combination of clomipramine and nortriptyline in the treatment of obsessive-compulsive disorder: a double-blind, placebo-controlled trial. Noorbala AA; Hosseini SH; Mohammadi MR; Akhondzadeh S J Clin Pharm Ther; 1998 Apr; 23(2):155-9. PubMed ID: 9786103 [TBL] [Abstract][Full Text] [Related]
24. Will pindolol augment the response to a serotonin reuptake inhibitor in obsessive-compulsive disorder? Koran LM; Mueller K; Maloney A J Clin Psychopharmacol; 1996 Jun; 16(3):253-4. PubMed ID: 8784659 [No Abstract] [Full Text] [Related]
25. Pharmacotherapy of obsessive-compulsive disorder: experience with the selective serotonin reuptake inhibitors. Vythilingum B; Cartwright C; Hollander E Int Clin Psychopharmacol; 2000 Aug; 15 Suppl 2():S7-13. PubMed ID: 11110014 [TBL] [Abstract][Full Text] [Related]
26. Evidence-based pharmacotherapy of obsessive-compulsive disorder. Fineberg NA; Gale TM Int J Neuropsychopharmacol; 2005 Mar; 8(1):107-29. PubMed ID: 15450126 [TBL] [Abstract][Full Text] [Related]
27. Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder. Barr LC; Goodman WK; Anand A; McDougle CJ; Price LH Am J Psychiatry; 1997 Sep; 154(9):1293-5. PubMed ID: 9286191 [TBL] [Abstract][Full Text] [Related]
28. Pareidolias in obsessive-compulsive disorder: neglected symptoms that may respond to serotonin reuptake inhibitors. Fontenelle LF Neurocase; 2008; 14(5):414-8. PubMed ID: 18850462 [TBL] [Abstract][Full Text] [Related]
29. Multivariate meta-analysis of controlled drug studies for obsessive-compulsive disorder. Ackerman DL; Greenland S J Clin Psychopharmacol; 2002 Jun; 22(3):309-17. PubMed ID: 12006902 [TBL] [Abstract][Full Text] [Related]
30. [Obsessive-compulsive disorder, frontostriatal system and the effect of the serotonergic system]. Baving L; Schmidt MH Z Kinder Jugendpsychiatr Psychother; 2000 Feb; 28(1):35-44. PubMed ID: 10746297 [TBL] [Abstract][Full Text] [Related]
31. Double-blind comparison of fluoxetine versus clomipramine in the treatment of obsessive compulsive disorder. López-Ibor JJ; Saiz J; Cottraux J; Note I; Viñas R; Bourgeois M; Hernández M; Gómez-Pérez JC Eur Neuropsychopharmacol; 1996 May; 6(2):111-8. PubMed ID: 8791036 [TBL] [Abstract][Full Text] [Related]